Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240

The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia

Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737

A systematic review of prevalence studies of dementia in Parkinson's disease

Aarsland, D., ZACCAI, J. H., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,714

Prevalence and Characteristics of Dementia in Parkinson Disease

Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403

Rivastigmine for Dementia Associated with Parkinson's Disease

Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., Deyn, P. P. D., Durif, F., Kulisevsky, J., van Laar, T., Lees, A. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,219

Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years

Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050

Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors

Fénelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,035

Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation

Grande, G., Cucumo, V., Cova, I., Ghiretti, R., Maggiore, L., Lacorte, E., Galimberti, D., Scarpini, E. A., Clerici, F., Pomati, S., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150786 · Cited by 39

Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson’s Disease1

Buongiorno, M., Antonelli, F., Compta, Y., Fernandez, Y., Pavı́a, J., Lomeña, F., Ríos, J., Ramírez, I., García, J. R., Soler, M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160698 · Cited by 39

Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson's disease

Abbasi, N., Mohajer, B., Abbasi, S., Hasanabadi, P., Abdolalizadeh, A., & Rajimehr, R. (2018) · Movement Disorders · doi:10.1002/mds.27284 · Cited by 38

Training working memory updating in Parkinson’s disease: A randomised controlled trial

Fellman, D., Salmi, J., Ritakallio, L., Ellfolk, U., Rinne, J. O., & Laine, M. (2018) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2018.1489860 · Cited by 40

Review: Revisiting the human cholinergic nucleus of the diagonal band of Broca

Liu, A. K. L., Lim, E., Ahmed, I., Chang, R. C., Pearce, R. K. B., & Gentleman, S. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12513 · Cited by 41

Reduced lateral occipital gray matter volume is associated with physical frailty and cognitive impairment in Parkinson’s disease

Chen, Y., Chen, H.-L., Lu, C., Chen, M., Chou, K., Tsai, N., Yu, C.-C., Chiang, P., & Lin, W. (2018) · European Radiology · doi:10.1007/s00330-018-5855-7 · Cited by 38

Lewy Body Dementias

Armstrong, M. J. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000685 · Cited by 39

Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial

Elder, G., Colloby, S., Firbank, M., McKeith, I., & Taylor, J.-P. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0465-9 · Cited by 30

‘Woe Betides Anybody Who Tries to Turn me Down.’ A Qualitative Analysis of Neuropsychiatric Symptoms Following Subthalamic Deep Brain Stimulation for Parkinson’s Disease

Mosley, P. E., Robinson, K., Coyne, T. J., Silburn, P. A., Breakspear, M. J., & Carter, A. (2019) · Neuroethics · doi:10.1007/s12152-019-09410-x · Cited by 39

The role of interaction and predictability in the spontaneous entrainment of movement.

Dotov, D. G., Cock, V. C. D., Gény, C., Ihalainen, P., Moens, B., Leman, M., Bardy, B. G., & Bella, S. D. (2019) · Journal of Experimental Psychology General · doi:10.1037/xge0000609 · Cited by 47

The diagnostic value of SNpc using NM-MRI in Parkinson’s disease: meta-analysis

Wang, X., Zhang, Y., Zhu, C., Li, G., Kang, J., Chen, F., & Yang, L. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04014-y · Cited by 39

Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study

Arnaldi, D., Donniaquio, A., Mattioli, P., Massa, F., Grazzini, M., Meli, R., Filippi, L., Grisanti, S. G., Famà, F., Terzaghi, M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191315 · Cited by 39

Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson’s disease patients

Leocadi, M., Canu, E., Donzuso, G., Stojković, T., Basaia, S., Kresojević, N. D., Stanković, I., Sarasso, E., Piramide, N., Tomić, A., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10713-4 · Cited by 41

The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study

Biundo, R., Weis, L., Fiorenzato, E., Pistonesi, F., Cagnin, A., Bertoldo, A., Anglani, M., Cecchin, D., & Antonini, A. (2021) · Brain Communications · doi:10.1093/braincomms/fcab180 · Cited by 39

Activation of N ‐methyl‐ D ‐aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of P arkinson's disease with dementia

Tsai, C., Huang, H., Liu, B., Li, C., Lu, M., Chen, X., Tsai, M. C., Yang, Y., & Lane, H. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12175 · Cited by 38

Thalamic volume and related visual recognition are associated with freezing of gait in non-demented patients with Parkinson's disease

Sunwoo, M. K., Cho, K. H., Hong, J. Y., Lee, J. E., Sohn, Y. H., & Lee, P. H. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.07.023 · Cited by 39

Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders

Deleidi, M., & Maetzler, W. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/391438 · Cited by 40

GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia

Maetzler, W., Deleersnijder, W., Hanssens, V., Bernard, A., Brockmann, K., Marquetand, J., Wurster, I., Rattay, T. W., Roncoroni, L., Schaeffer, E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149349 · Cited by 36

An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease

Cantürk, P. U., Hanagasi, H. A., Bılgıç, B., Gurvit, H. I., & Emre, M. (2017) · European Journal of Neurology · doi:10.1111/ene.13467 · Cited by 39

Neuropsychiatric feature profiles of patients with Lewy body dementia

de Oliveira, F. F., Machado, F. C., Sampaio, G., Marin, S. D. M. C., Naffah‐Mazzacoratti, M. D. G., & Bertolucci, P. H. F. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.105832 · Cited by 38

Microstructural but not macrostructural cortical degeneration occurs in Parkinson’s disease with mild cognitive impairment

Bai, X., Guo, T., Chen, J., Guan, X., Zhou, C., Wu, J., Liu, X., Wu, H., Wen, J., Gu, L., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00416-6 · Cited by 38

Helicobacter pylori infection, dementia and primary open-angle glaucoma: are they connected?

Tsolaki-Tagaraki, F., Kountouras, J., Topouzis, F., & Tsolaki, M. (2015) · BMC Ophthalmology · doi:10.1186/s12886-015-0006-2 · Cited by 38

Amyloid-β and τ biomarkers in Parkinson's disease–dementia

Buongiorno, M., Compta, Y., & Martı́, M. J. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.06.046 · Cited by 39

SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes

Mutez, E., Leprêtre, F., Rhun, É. L., Larvor, L., Duflot, A., Mouroux, V., Kerckaert, J., Figeac, M., Dujardin, K., Destée, A., et al. (2011) · Human Mutation · doi:10.1002/humu.21459 · Cited by 38

Mild Cognitive Impairment: An Update in Parkinson’s Disease and Lessons Learned from Alzheimer’s Disease

Goldman, J. G., Aggarwal, N. T., & Schroeder, C. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.34 · Cited by 40

Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting

Fengler, S., Kessler, J., Timmermann, L., Zapf, A. C., Elben, S., Wojtecki, L., Tucha, O. M., & Kalbe, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159318 · Cited by 40

Effects of carbonated liquid on swallowing dysfunction in dementia with Lewy bodies and Parkinson’s disease dementia

Larsson, V., Torisson, G., Bülow, M., & Londos, E. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s140389 · Cited by 38

Systemic Inflammation in Lewy Body Diseases

King, E., & Thomas, A. J. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000211 · Cited by 38

Cognitive impairment in Parkinson's disease is associated with Default Mode Network subsystem connectivity and cerebrospinal fluid Aβ

Zarifkar, P., Kim, J., La, C., Zhang, K., YorkWilliams, S. L., Levine, T. F., Tian, L., Borghammer, P., & Poston, K. L. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.01.002 · Cited by 39

Cortical connectivity of the nucleus basalis of Meynert in Parkinson’s disease and Lewy body dementias

Oswal, A., Gratwicke, J., Akram, H., Jahanshahi, M., Záborszky, L., Brown, P., Hariz, M. I., Zrinzo, L. U., Foltynie, T., & Vladimir Litvak, A. (2020) · Brain · doi:10.1093/brain/awaa411 · Cited by 38

Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease

Carmichael, K., Sullivan, B. T., Lopez, E., Sun, L., & Cai, H. (2021) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2021.07 · Cited by 48

Therapy-resistant symptoms in Parkinson’s disease

Vorovenci, R. J., Biundo, R., & Antonini, A. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1463-8 · Cited by 38

Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration

Gaig, C., Ezquerra, M., Martı́, M. J., Valldeoriola, F., Muñoz, E., Lladó, A., Rey, M. J., Cardozo, A., Molinuevo, J. L., & TOLOSA, E. S. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.02.010 · Cited by 38

Predictors of Discrepancies in Parkinson's Disease Patient and Caregiver Ratings of Apathy, Disinhibition, and Executive Dysfunction before and after Diagnosis

Schiehser, D. M., Liu, L., Lessig, S. L., Song, D. D., Obtera, K. M., Burke, M. M., Earl, S. R., & Filoteo, J. V. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617712001385 · Cited by 38

Cortical phosphorylated α‐Synuclein levels correlate with brain wave spectra in Parkinson's disease

Caviness, J. N., Lue, L., Hentz, J. G., Schmitz, C. T., Adler, C. H., Shill, H. A., Sabbagh, M. N., Beach, T. G., & Walker, D. G. (2016) · Movement Disorders · doi:10.1002/mds.26621 · Cited by 37

Neuroimaging studies of striatum in cognition part II: Parkinson's disease

Hanganu, A., Provost, J.-S., & Monchi, O. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00138 · Cited by 37

Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?

Yarnall, A. J., Lashley, T., Ling, H., Lees, A. J., Coleman, S. Y., O’Sullivan, S. S., Compta, Y., Révész, T., & Burn, D. J. (2015) · Movement Disorders · doi:10.1002/mds.26422 · Cited by 37

Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy

Giordano, A., Tessitore, A., Corbo, D., Cirillo, G., Micco, R. D., Russo, A., Liguori, S., Cirillo, M., Esposito, F., & Tedeschi, G. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.02.005 · Cited by 38

Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants

Nuytemans, K., Maldonado, L. G., Ali, A., John‐Williams, K., Beecham, G. W., Martin, E. R., Scott, W. K., & Vance, J. M. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000044 · Cited by 37

Early and progressive microstructural brain changes in mice overexpressing human α-Synuclein detected by diffusion kurtosis imaging

Khairnar, A., Kučerová, J., Szabó, N., Dražanová, E., Arab, A., Hutter‐Paier, B., Neddens, J., Latta, P., Starčuk, Z., & Rektorová, I. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.11.027 · Cited by 37

Memory impairment in Parkinson’s disease: The retrieval versus associative deficit hypothesis revisited and reconciled.

Bezdíček, O., Ballarini, T., Herman Buschke, L., Růžička, F., Roth, J., Albrecht, F., Růžička, E., Mueller, K., Schroeter, M. L., & Jech, R. (2019) · Neuropsychology · doi:10.1037/neu0000503 · Cited by 38

Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson’s disease

Pezzoli, S., Cagnin, A., Antonini, A., & Venneri, A. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1656515 · Cited by 37

Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson’s disease dementia

Hansen, D., Ling, H., Lashley, T., Foley, J. A., Strand, C., Eid, T. M., Holton, J. L., & Warner, T. T. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12648 · Cited by 38

Neuropsychiatric and Cognitive Deficits in Parkinson’s Disease and Their Modeling in Rodents

Decourt, M., Jiménez‐Urbieta, H., Benoit‐Marand, M., & Fernagut, P. (2021) · Biomedicines · doi:10.3390/biomedicines9060684 · Cited by 37

Orbital and ventromedial prefrontal cortex functioning in Parkinson’s disease: Neuropsychological evidence

Poletti, M., & Bonuccelli, U. (2012) · Brain and Cognition · doi:10.1016/j.bandc.2012.02.002 · Cited by 37

PDD‐Short Screen: A brief cognitive test for screening dementia in Parkinson's disease

Pagonabarraga, J., Kulisevsky, J., Llebaria, G., García‐Sánchez, C., Pascual‐Sedano, B., Martinez‐Corral, M., & Gironell, A. (2010) · Movement Disorders · doi:10.1002/mds.22877 · Cited by 37

SCOPA‐cognition cutoff value for detection of Parkinson's disease dementia

Verbaan, D., Jeukens‐Visser, M., van Laar, T., van Rooden, S. M., van Zwet, E. W., Marinus, J., & van Hilten, J. J. (2011) · Movement Disorders · doi:10.1002/mds.23750 · Cited by 37

Onset of Mild Cognitive Impairment in Parkinson Disease

Johnson, D. K., Langford, Z. D., Garnier‐Villarreal, M., Morris, J. C., & Galvin, J. E. (2015) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000088 · Cited by 37

A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias

Bolsewig, K., Hok-A-Hin, Y. S., Sepe, F. N., Boonkamp, L., Jacobs, D., Bellomo, G., Paoletti, F. P., Vanmechelen, E., Teunissen, C. E., Parnetti, L., et al. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220318 · Cited by 36

α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation

Kuang, Y., Mao, H., Huang, X., Chen, M., Dai, W. H., Gan, T., Wang, J., Sun, H., Lin, H., Liu, Q., et al. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00449-2 · Cited by 37

Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease

Christopher, L., & Strafella, A. P. (2013) · Journal of Neuropsychology · doi:10.1111/jnp.12015 · Cited by 36

The common dementias: a pictorial review

Bhogal, P., Mahoney, C., Graeme-Baker, S., Roy, A., Shah, S., Fraioli, F., Cowley, P., & Jäger, H. R. (2013) · European Radiology · doi:10.1007/s00330-013-3005-9 · Cited by 37

Depression Impairs Executive Functioning in Parkinson Disease Patients With Low Educational Level

Kümmer, A., Harsányi, E., Dias, F. M. V., Cardoso, F., Caramelli, P., & Teixeira, A. L. (2009) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3181b278f9 · Cited by 36

The prevalence and risk factors of cerebral microbleeds in patients with Parkinson's disease

Yamashiro, K., Tanaka, R., Hoshino, Y., Hatano, T., Nishioka, K., & Hattori, N. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.06.019 · Cited by 37

Impact of Falls on Physical Activity in People with Parkinson’s Disease

Hiorth, Y. H., Larsen, J. P., Lode, K., Tysnes, O., Godfrey, A., Lord, S., Rochester, L., & Pedersen, K. F. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150640 · Cited by 36

Evaluating the performance of the Montreal Cognitive Assessment in early stage Parkinson's disease

Kletzel, S., Hernandez, J. M., Miskiel, E. F., Mallinson, T., & Pape, T. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.01.012 · Cited by 36

Cognitive impairment is associated with Hoehn and Yahr stages in early, de novo Parkinson disease patients

Siciliano, M., Micco, R. D., Trojano, L., Stefano, M. D., Baiano, C., Passaniti, C., Mase, A. D., Russo, A., Tedeschi, G., & Tessitore, A. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.05.020 · Cited by 36

Coping with Cognitive Impairment in People with Parkinson’s Disease and Their Carers: A Qualitative Study

Lawson, R. A., Collerton, D., Taylor, J., Burn, D. J., & Brittain, K. (2018) · Parkinson s Disease · doi:10.1155/2018/1362053 · Cited by 36

Current treatment of behavioral and cognitive symptoms of Parkinson's disease

Rektorová, I. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.02.042 · Cited by 36

Cognitive complaints in Parkinson’s disease patients: from subjective cognitive complaints to dementia and affective disorders

Barbosa, R. P., Mendonça, M., Caetano, A., Lampreia, T., Miguel, R., & Bugalho, P. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02042-8 · Cited by 36

Utility of the D-KEFS Color Word Interference Test as an embedded measure of performance validity

Eglit, G. M. L., Jurick, S. M., Delis, D. C., Filoteo, J. V., Bondi, M. W., & Jak, A. J. (2019) · The Clinical Neuropsychologist · doi:10.1080/13854046.2019.1643923 · Cited by 39

Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson’s Disease

Chen, C., Lee, B., & Lin, C. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191766 · Cited by 36

Treatment of Nonmotor Symptoms Associated with Parkinson Disease

Goldman, J. G., & Guerra, C. M. (2020) · Neurologic Clinics · doi:10.1016/j.ncl.2019.12.003 · Cited by 36

REM Sleep Behavior Disorder in Parkinson’s Disease: Effects on Cognitive, Psychiatric, and Functional outcomes

Mahmood, Z., Patten, R. V., Nakhla, M. Z., Twamley, E. W., Filoteo, J. V., & Schiehser, D. M. (2020) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617720000430 · Cited by 36

Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease

Han, L., Tang, Y., Bai, X., Liang, X., Fan, Y., Shen, Y., Huang, F., & Wang, J. (2020) · Aging · doi:10.18632/aging.103458 · Cited by 36

Anxiety in Parkinson's disease is associated with changes in the brain fear circuit

Carey, G., Lopes, R., Viard, R., Betrouni, N., Kuchcinski, G., Devignes, Q., Defebvre, L., Leentjens, A. F. G., & Dujardin, K. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.09.020 · Cited by 41

Subjective cognitive decline in idiopathic Parkinson´s disease: A systematic review

Oedekoven, C., Egeri, L., Jessen, F., Wagner, M., & Dodel, R. C. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101508 · Cited by 36

Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study

Bäckström, D. C., Granåsen, G., Mo, S. J., Riklund, K., Trupp, M., Zetterberg, H., Blennow, K., Forsgren, L., & Domellöf, M. E. (2022) · Brain Communications · doi:10.1093/braincomms/fcac040 · Cited by 42

Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson’s disease

Bickel, S. G., Alvarez, L. M., Macías, R. J., Fuentes, N. P., Leon, M., Fernández, C., Houghton, D. J., Salazar, S., Rodríguez‐Oroz, M., Juncos, J. L., et al. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.06.008 · Cited by 36

Cognitive change on the repeatable battery of neuropsychological status (RBANS) in parkinson's disease with and without bilateral subthalamic nucleus deep brain stimulation surgery

Rinehardt, E., Duff, K. M., Schoenberg, M. R., Mattingly, M., Bharucha, K. J., & Scott, J. C. (2010) · The Clinical Neuropsychologist · doi:10.1080/13854046.2010.521770 · Cited by 36

A short Scale for Evaluation of Neuropsychiatric Disorders in Parkinson’s Disease: first psychometric approach

Martínez‐Martín, P., Payo, B. F., Agüera-Ortíz, L., & Ayuga-Martinez, A. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6490-x · Cited by 36

Contribution of Quantitative EEG to the Diagnosis of Early Cognitive Impairment in Patients With Idiopathic Parkinson’s Disease

Guner, D., Tiftikcioglu, B. I., Tuncay, N., & Zorlu, Y. (2017) · Clinical EEG and Neuroscience · doi:10.1177/1550059416662412 · Cited by 33

Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment

Altmann, V., Schumacher-Schuh, A. F., Rieck, M., Callegari-Jacques, S. M., Rieder, C. R. M., & Hutz, M. H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.030 · Cited by 43

Functional connectivity in Parkinson’s disease candidates for deep brain stimulation

Albano, L., Agosta, F., Basaia, S., Cividini, C., Stojković, T., Sarasso, E., Stanković, I., Tomić, A., Marković, V., Stefanova, E. D., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-021-00268-6 · Cited by 35

International Parkinson and Movement Disorder Society Viewpoint on Biological Frameworks of Parkinson's Disease: Current Status and Future Directions

Kalia, L. V., Berg, D., Kordower, J. H., Shannon, K. M., Taylor, J., Cardoso, F., Goldman, J. G., Jeon, B., Meissner, W. G., Tijssen, M. A. J., et al. (2024) · Movement Disorders · doi:10.1002/mds.30007 · Cited by 35

Assessing apathy in everyday clinical practice with the short‐form Lille Apathy Rating Scale

Dujardin, K., Sockeel, P., Carette, A., Delliaux, M., & Defebvre, L. (2013) · Movement Disorders · doi:10.1002/mds.25584 · Cited by 35

Recent Research Progress in and Future Perspective on Treatment of Parkinson's Disease

Mizuno, Y. (2014) · Integrative Medicine International · doi:10.1159/000365571 · Cited by 35

Dopamine signals and physiological origin of cognitive dysfunction in Parkinson's disease

Matsumoto, M. (2015) · Movement Disorders · doi:10.1002/mds.26177 · Cited by 37

Predictors of performance-based measures of instrumental activities of daily living in nondemented patients with Parkinson’s disease

Pirogovsky, E., Martinez-Hannon, M., Schiehser, D. M., Lessig, S. L., Song, D. D., Litvan, I., & Filoteo, J. V. (2013) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2013.838940 · Cited by 35

Clusterin CSF levels in differential diagnosis of neurodegenerative disorders

Vranová, H. P., Hényková, E., Mareš, J., Kaiserová, M., Menšíková, K., Vaštík, M., Hluštı́k, P., Zapletalová, J., Strnad, M., Stejskal, D., et al. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.12.023 · Cited by 35

People with dementia in nursing home research: a methodological review of the definition and identification of the study population

Palm, R., Jünger, S., Reuther, S., Schwab, C. G. G., Dichter, M., Holle, B., & Halek, M. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0249-7 · Cited by 35

Loss of phosphodiesterase 4 in Parkinson disease

Niccolini, F., Wilson, H., Pagano, G., Coello, C. S., Mehta, M. A., Searle, G. E., Gunn, R. N., Rabiner, E. A., Foltynie, T., & Politis, M. (2017) · Neurology · doi:10.1212/wnl.0000000000004201 · Cited by 36

Educational attainment and motor burden in advanced Parkinson's disease – The emerging role of education in motor reserve

Waldthaler, J., Rothenfusser, E., Schlaier, J. R., Bogdahn, U., & Lange, M. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.3241 · Cited by 35

Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson’s disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome

van Horne, C. G., Quintero, J. E., Slevin, J. T., Anderson-Mooney, A. J., Gurwell, J. A., Welleford, A. S., Lamm, J. R., Wagner, R. P., & Gerhardt, G. A. (2018) · Journal of neurosurgery · doi:10.3171/2017.8.jns163222 · Cited by 35

Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson’s disease patients

Chondrogiorgi, M., Astrakas, L. G., Zikou, A. K., Weis, L., Xydis, V. G., Antonini, A., Argyropoulou, M. I., & Konitsiotis, S. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9863-7 · Cited by 35

Review: Clinical, neuropathological and genetic features of Lewy body dementias

Hansen, D., Ling, H., Lashley, T., Holton, J. L., & Warner, T. T. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12554 · Cited by 41

Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases

Llorens, F., Villar‐Piqué, A., Schmitz, M., Lucena, D. D., Wohlhage, M. C., Hermann, P., Goebel, S., Schmidt, I., Glatzel, M., Hauw, J., et al. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12573 · Cited by 35

Functional Inhibitory Control Dynamics in Impulse Control Disorders in Parkinson's Disease

Paz‐Alonso, P. M., Navalpotro‐Gómez, I., Boddy, P., Dacosta‐Aguayo, R., Delgado‐Alvarado, M., Quiroga‐Varela, A., Jiménez‐Urbieta, H., Carreiras, M., & Rodríguez-Oroz, M. C. (2019) · Movement Disorders · doi:10.1002/mds.27885 · Cited by 38

Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in “cognitive status” converters?

Gorges, M., Kunz, M. S., Müller, H., Liepelt‐Scarfone, I., Storch, A., Dodel, R. C., Hilker‐Roggendorf, R., Berg, D., Kalbe, E., Braak, H., et al. (2019) · Human Brain Mapping · doi:10.1002/hbm.24884 · Cited by 35

Impairments in face discrimination and emotion recognition are related to aging and cognitive dysfunctions in Parkinson’s disease with dementia

Ho, M. W.-R., Chien, S. H., Lu, M., Chen, J., Aoh, Y., Chen, C., Lane, H., & Tsai, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-61310-w · Cited by 36

Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein–Containing Extracellular Vesicles

Hong, Z., Tian, C., Stewart, T., Aro, P., Soltys, D., Bercow, M., Sheng, L., Borden, K., Khrisat, T., Pan, C., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011853 · Cited by 36

Integration of Virtual Reality into Transcranial Magnetic Stimulation Improves Cognitive Function in Patients with Parkinson’s Disease with Cognitive Impairment: A Proof-of-Concept Study

Cheng, T.-C., Huang, S.-F., Wu, S.-Y., Lin, F.-G., Lin, W.-S., & Tsai, P.-Y. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212978 · Cited by 35

Serum NFL discriminates Parkinson disease from essential tremor and reflect motor and cognition severity

Huang, Y., Huang, C., Zhang, Q., Shen, T., & Sun, J. (2022) · BMC Neurology · doi:10.1186/s12883-022-02558-9 · Cited by 34

Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson’s disease dementia

Frigerio, I., Laansma, M. A., Lin, C., Hermans, E. J. M., Bouwman, M. M. A., Bol, J. G. J. M., Graaf, Y. G.-D., Hepp, D. H., Rozemüller, A. J. M., Barkhof, F., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-022-00328-8 · Cited by 35

Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives

Mantovani, E., Zucchella, C., Argyriou, A. A., & Tamburin, S. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2173576 · Cited by 35

Human striatal glia differentially contribute to AD- and PD-specific neurodegeneration

Xu, J., Farsad, H. L., Hou, Y., Barclay, K. M., Lopez, B. A., Yamada, S., Saliu, I. O., Shi, Y., Knight, W. C., Bateman, R. J., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00363-8 · Cited by 39

Biomarkers for Cognitive Impairment in Parkinson Disease

Shi, M. Y., Huber, B. R., & Zhang, J. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00370.x · Cited by 35

White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's disease

Compta, Y., Buongiorno, M., Bargalló, N., Valldeoriola, F., Muñoz, E., TOLOSA, E. S., Ríos, J., Cámara, A., Fernández, M., & Martı́, M. J. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.06.009 · Cited by 35

Multidimensional care burden in Parkinson-related dementia

Vatter, S., McDonald, K. R., Stanmore, E., Clare, L., & Leroi, I. (2018) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988718802104 · Cited by 46

Contrasts Between Patients With Lewy Body Dementia Syndromes and APOE-ε3/ε3 Patients With Late-onset Alzheimer Disease Dementia

de Oliveira, F. F., Machado, F. C., Sampaio, G., Marin, S. D. M. C., Chen, E., Smith, M. D. A. C., & Bertolucci, P. H. F. (2015) · The Neurologist · doi:10.1097/nrl.0000000000000045 · Cited by 34

Dementia in Parkinson's Disease

Burn, D. J. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00012-x · Cited by 17

Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis

Goetz, C. G., Emre, M., & Dubois, B. (2009) · Annals of Neurology · doi:10.1002/ana.21455 · Cited by 232

Diagnosis and Treatment of Parkinson's Disease Dementia : An Update

Park, M. Y. (2007) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2007.24.2s.s159

Clinical phenotype of Parkinson disease dementia

Galvin, J. E., Pollack, J., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000242630.52203.8f · Cited by 264

Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria

Martínez‐Martín, P., Falup‐Pecurariu, C., Rodríguez‐Blázquez, C., Serrano‐Dueñas, M., Artal, F. J. C., Rojo-Abuín, J. M., & Aarsland, D. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.05.017 · Cited by 64